bisbenzimidazole has been researched along with Psoriasis in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novotný, J | 1 |
| Pospechová, K | 1 |
| Hrabálek, A | 1 |
| Cáp, R | 1 |
| Vávrová, K | 1 |
1 other study available for bisbenzimidazole and Psoriasis
| Article | Year |
|---|---|
Synthesis of fluorescent C24-ceramide: evidence for acyl chain length dependent differences in penetration of exogenous NBD-ceramides into human skin.
Topics: 4-Chloro-7-nitrobenzofurazan; Bisbenzimidazole; Ceramides; Dermatitis, Atopic; Fluorescence; Fluores | 2009 |